Managing_Opioid-Induced_Constipation

First Page		Document Content
Date: 2014-02-04 18:20:56 Morphinans Ketones Phenols Alcohols Opioid antagonists Opioid Methylnaltrexone Fecal impaction Constipation Chemistry Medicine Organic chemistry		Managing_Opioid-Induced_Constipation Add to Reading List Source URL: www.2ndchance.info Download Document from Source Website File Size: 176,13 KB Share Document on Facebook

	NOT FOR IMMEDIATE RELEASE SHIONOGI & CO., LTD ANNOUNCES THAT NALDEMEDINE MEETS PRIMARY ENDPOINT IN A PHASE 3 STUDY FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION FLORHAM PARK, NJ (March 30, 2015) – Naldemedine, an i DocID: 1a9hD - View Document
	Needham & Company 2015 Healthcare Conference Stephen Doberstein, Ph.D. Senior Vice President & Chief Scientific Officer April 15, 2015 DocID: 180Xh - View Document
	Managing_Opioid-Induced_Constipation DocID: 17ZAz - View Document
	Methylnaltrexone (Relistor®) A novel treatment for opioid-induced constipation http://www.healthandherbs.co.nz/Health-Library/Digestion--Gastrointestinal-Health/Resveratrol-for-Digestive-Health/default.aspx Heather A. DocID: SaTR - View Document
	TXT_PI_US_Relistor_20mg/mL Injectable_4.0 DocID: RGh1 - View Document